Literature DB >> 8425681

Impaired hydrogen metabolism in pneumatosis cystoides intestinalis.

S U Christl1, G R Gibson, P R Murgatroyd, W Scheppach, J H Cummings.   

Abstract

BACKGROUND: Pneumatosis cystoides intestinalis (PCI) is characterized by high levels of breath hydrogen. Clinical features of PCI may be due to abnormal H2 metabolism.
METHODS: Breath levels of H2 and CH4 were measured in 3 patients and total gas in 2 patients with PCI on a polysaccharide-free (basal) diet and after administration of 15 g of lactulose. Metabolic activities and counts of methanogenic (MB) and sulfate-reducing (SRB) bacteria were measured in feces. Ten volunteers were also studied.
RESULTS: Total H2 levels in patients were 383-420 mL/day on the basal diet and 1430-1730 mL/day after lactulose administration compared with 35 +/- 6 mL/day and 262 +/- 65 mL/day, respectively, in controls. Basal breath H2 levels in controls were 27 +/- 6 vs. 214 +/- 27 mL/day in patients and after lactulose ingestion, 115 +/- 18 vs. 370 +/- 72 mL/day. Four controls were methanogenic and had high fecal MB counts. The other controls had high SRB counts and sulfate reduction rates. All patients were nonmethanogenic and had low sulfate reduction rates.
CONCLUSIONS: Patients with PCI excrete more H2 than controls. In normal subjects, H2 is consumed by MB or SRB; the activity of these bacteria is virtually absent in PCI. This may explain the gas accumulation in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425681     DOI: 10.1016/0016-5085(93)90406-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Pneumatosis intestinalis with Clostridium difficile colitis as a cause of acute abdomen after lung transplantation.

Authors:  P Schenk; C Madl; L Kramer; K Ratheiser; A Kranz; C Zauner; C Stain; T Birsan; W Klepetko; C Müller
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

2.  Alkyl halides, super hydrogen production and the pathogenesis of pneumatosis cystoides coli.

Authors:  T H Florin
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

3.  Lactulose-induced pneumatosis intestinalis and pneumoperitoneum.

Authors:  R A Goodman; T R Riley
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Fecal hydrogen production and consumption measurements. Response to daily lactose ingestion by lactose maldigesters.

Authors:  S R Hertzler; D A Savaiano; M D Levitt
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  Pneumatosis intestinalis in a child with nephrotic syndrome and norovirus gastroenteritis.

Authors:  Winnie K Y Chan; Kwok Wai Lee; Tsz Wo Fan
Journal:  Pediatr Nephrol       Date:  2010-03-11       Impact factor: 3.714

6.  Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report.

Authors:  Justin Roy; Mitchell Kang; Benjamin Stern; Thomas Riley; Ian Schreibman
Journal:  Clin J Gastroenterol       Date:  2021-03-27

Review 7.  Pneumatosis intestinalis. Two case reports and a retrospective review of the literature from 1985 to 1995.

Authors:  R M Boerner; D B Fried; D M Warshauer; K Isaacs
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 8.  Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone.

Authors:  G E Cabrera; E Scopelitis; M L Cuellar; L H Silveira; H Mena; L R Espinoza
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

Review 9.  Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment: a case report and review of the literature.

Authors:  Tatsuhiro Tsujimoto; Erika Shioyama; Kei Moriya; Hideto Kawaratani; Yasuyo Shirai; Masahisa Toyohara; Akira Mitoro; Jun Yamao; Hisao Fujii; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

10.  Colonic fermentation: metabolic and clinical implications.

Authors:  K H Soergel
Journal:  Clin Investig       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.